Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.
| Image |  |
|---|---|
| Description | scientific article published on 13 October 2016 |
| Author/s |
author: Javier Benitez Diego Megías Alvaro Monteiro Sergio Gomez-Lopez Manel Esteller Ana Osorio |
| Publication date | December 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |